Publication result detail

Colorectal tumour mucosa microbiome is enriched in oral pathogens and defines three subtypes that correlate with markers of tumour progression

ZWINSOVÁ, B.; PETROV, V.; HRIVŇÁKOVÁ, M.; SMATANA, S.; MICENKOVÁ, L.; KAZDOVÁ, N.; POPOVICI, V.; HRSTKA, R.; ŠEFR, R.; BENCSIKOVÁ, B.; ZDRAŽILOVÁ-DUBSKÁ, L.; BRYCHTOVÁ, V.; NENUTIL, R.; VÍDEŇSKÁ, P.; BUDINSKÁ, E.

Original Title

Colorectal tumour mucosa microbiome is enriched in oral pathogens and defines three subtypes that correlate with markers of tumour progression

English Title

Colorectal tumour mucosa microbiome is enriched in oral pathogens and defines three subtypes that correlate with markers of tumour progression

Type

WoS Article

Original Abstract

Long-term dysbiosis of the gut microbiome has a significant impact on colorectal cancer (CRC) progression and explains part of the observed heterogeneity of the disease. Even though the shifts in gut microbiome in the normal-adenoma-carcinoma sequence were described, the landscape of the microbiome within CRC and its associations with clinical variables remain under-explored. We performed 16S rRNA gene sequencing of paired tumour tissue, adjacent visually normal mucosa and stool swabs of 178 patients with stage 0IV CRC to describe the tumour microbiome and its association with clinical variables. We identified new genera associated either with CRC tumour mucosa or CRC in general. The tumour mucosa was dominated by genera belonging to oral patho-gens. Based on the tumour microbiome, we stratified CRC patients into three subtypes, significantly associated with prognostic factors such as tumour grade, sidedness and TNM staging, BRAF mutation and MSI status. We found that the CRC microbiome is strongly correlated with the grade, location and stage, but these associations are dependent on the microbial environment. Our study opens new research avenues in the microbiome CRC biomarker detection of disease progression while identifying its limitations, suggesting the need for combining several sampling sites (e.g., stool and tumour swabs).

English abstract

Long-term dysbiosis of the gut microbiome has a significant impact on colorectal cancer (CRC) progression and explains part of the observed heterogeneity of the disease. Even though the shifts in gut microbiome in the normal-adenoma-carcinoma sequence were described, the landscape of the microbiome within CRC and its associations with clinical variables remain under-explored. We performed 16S rRNA gene sequencing of paired tumour tissue, adjacent visually normal mucosa and stool swabs of 178 patients with stage 0IV CRC to describe the tumour microbiome and its association with clinical variables. We identified new genera associated either with CRC tumour mucosa or CRC in general. The tumour mucosa was dominated by genera belonging to oral patho-gens. Based on the tumour microbiome, we stratified CRC patients into three subtypes, significantly associated with prognostic factors such as tumour grade, sidedness and TNM staging, BRAF mutation and MSI status. We found that the CRC microbiome is strongly correlated with the grade, location and stage, but these associations are dependent on the microbial environment. Our study opens new research avenues in the microbiome CRC biomarker detection of disease progression while identifying its limitations, suggesting the need for combining several sampling sites (e.g., stool and tumour swabs).

Keywords

16S rRNA gene, Colorectal cancer, Microbial subtypes, Tumour microbiome

Key words in English

16S rRNA gene, Colorectal cancer, Microbial subtypes, Tumour microbiome

Authors

ZWINSOVÁ, B.; PETROV, V.; HRIVŇÁKOVÁ, M.; SMATANA, S.; MICENKOVÁ, L.; KAZDOVÁ, N.; POPOVICI, V.; HRSTKA, R.; ŠEFR, R.; BENCSIKOVÁ, B.; ZDRAŽILOVÁ-DUBSKÁ, L.; BRYCHTOVÁ, V.; NENUTIL, R.; VÍDEŇSKÁ, P.; BUDINSKÁ, E.

RIV year

2023

Released

01.10.2021

ISBN

2072-6694

Periodical

Cancers

Volume

13

Number

19

State

Swiss Confederation

Pages from

1

Pages to

25

Pages count

25

URL

BibTex

@article{BUT182946,
  author="ZWINSOVÁ, B. and PETROV, V. and HRIVŇÁKOVÁ, M. and SMATANA, S. and MICENKOVÁ, L. and KAZDOVÁ, N. and POPOVICI, V. and HRSTKA, R. and ŠEFR, R. and BENCSIKOVÁ, B. and ZDRAŽILOVÁ-DUBSKÁ, L. and BRYCHTOVÁ, V. and NENUTIL, R. and VÍDEŇSKÁ, P. and BUDINSKÁ, E.",
  title="Colorectal tumour mucosa microbiome is enriched in oral pathogens and defines three subtypes that correlate with markers of tumour progression",
  journal="Cancers",
  year="2021",
  volume="13",
  number="19",
  pages="1--25",
  doi="10.3390/cancers13194799",
  url="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507728/"
}